Latest Als News

DataWorks has secured a significant contract extension with iGaming Ontario, adding over C$12.5 million to its Centralised Self-Exclusion program services. This move strengthens its recurring revenue and solidifies its RegTech division’s profitability.

EV Resources has launched its first-ever diamond drilling program at the Los Lirios Antimony Project in Mexico, aiming to unlock the potential of a historically high-grade mineral system. The company is also refining assay methods to ensure accurate measurement of antimony content.

Small caps did the heavy lifting this week, led by two big discovery stories in resources. Funding raises and takeover moves kept attention on who can pay for the next step, not just promise it.

A handful of healthcare names did the heavy lifting this week, driven by FDA wins, guideline upgrades, and big shifts in sales and cashflow. The flip side: several clinical-stage stocks fell hard as investors stayed picky about near-term proof and funding.

Invictus Energy has reached a pivotal milestone by finalising the Petroleum Production Sharing Agreement for its Cabora Bassa Project, setting the stage for exploration and appraisal drilling in Zimbabwe in 2026. Meanwhile, the company has ended its strategic partnership with Al Mansour Holdings and is actively pursuing new funding avenues.

Enterprise Metals has completed a targeted drilling campaign at its Cuddingwarra North rare earth prospect, delivering 906 metres of samples now awaiting assay results. The program aims to unlock the potential of this strategically located tenement adjacent to Victory Metals’ resource.

Solara Minerals has completed the first stage of drilling at its promising Degrussa West gold-copper project, with assay results expected soon. The company also secured a $180,000 government grant to support further exploration across its Bryah Basin portfolio.

Neurizon Therapeutics has cleared a major regulatory hurdle with the FDA lifting the clinical hold on its lead drug NUZ-001 and secured a comprehensive $33 million funding package to advance its pivotal ALS trial.

Solis Minerals has made a decisive leap in its Peruvian copper-gold exploration with the acquisition of the Cucho Project and a successful $5.9 million capital raise, setting the stage for an active 2026 drilling campaign.

New Frontier Minerals has completed its maiden drilling campaign at Harts Range and secured a binding commercial framework with Metallium Ltd, unlocking a novel processing pathway for heavy rare earth elements. Meanwhile, progress at its NWQ Copper Project and a successful capital raise position the company for growth.

Alara Resources has reported its strongest quarterly copper concentrate production and dispatch at the Al Wash-hi Majaza Mine, alongside expanded exploration efforts across Oman and strengthened financial footing through new loan facilities.

Neurizon Therapeutics has locked in a $6 million cash rebate from the Australian Government’s R&D Tax Incentive, underpinning its upcoming HEALEY ALS Platform Trial with first patient dosing slated for early 2026.